Joyce Ohm, PhD

Associate Professor of Oncology
Department of Cancer Genetics and Genomics
Roswell Park Comprehensive Cancer Center
Special Interests: 
Cancer epigenetics
Environmental exposures and tumor initiation
Translocation associated sarcomas
Stem cell biology and cellular reprogramming
Molecular signatures for lung cancer


After completing a Ph.D. in Cancer Biology with Dr. David Carbone at Vanderbilt University School of Medicine in 2003, I accepted a post-doctoral fellowship in the laboratory of Dr. Stephen Baylin at the Johns Hopkins School of Medicine studying abnormal epigenetic gene silencing of tumor suppressor genes in cancer. Dr. Baylin is a pioneer in the field of epigenetics and this was a tremendous opportunity for me to initiate a series of projects which link aberrant epigenetic programs with the normal epigenetic remodeling that is essential in order for a stem/progenitor cell to properly differentiate.

I then established my independent laboratory at the University of North Dakota School of Medicine and Health Sciences and helped to build an NIH funded Center of Biomedical Research Excellence focused on studying the epigenomics of development and disease.

My overall training has helped to lay a strong foundation in epigenetics, as well as genome-wide expression, methylation, and chromatin analysis platforms.


Education and Training: 
2003 - PhD - Cancer Biology - Vanderbilt University, Nashville, TN
2009 - Post-doctoral fellowship - Oncology - The Johns Hopkins University, Baltimore, MD